MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12885-024-13108-6

Медицинская библиотека · BMC cancer · 2024

Investigating the role of non-synonymous variant D67N of ADGRE2 in chronic myeloid leukemia.

Afzal Ayesha, Jamshaid Harooma, Badshah Yasmin, Shabbir Maria, Trembley Janeen H, Zafar Sameen, Kamal Ghulam Murtaza, Afsar Tayyaba, Husain Fohad Mabood, Razak Suhail

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Chronic myeloid leukaemia (CML) is a type of blood cancer that begins in the hematopoietic stem cells. It is primarily characterized by a specific chromosomal aberration, the Philadelphia chromosome. While the fusion gene is a major contributor to CML, several other genes including ADGRE2, that are reported as highly expressed in hematopoietic stem cells and could be utilized as a therapeutic marker in leukemic patients are implicated in the disease's progression. Until recently, little research had been conducted to identify single nucleotide polymorphisms (SNPs) associated with CML. Therefore, this study aims to investigate the influence of non-synonymous variants on the structure and function of the gene encoding adhesion G protein-coupled receptor E2, ADGRE2, and to evaluate their association with CML and its clinical and pathological characteristics.

METHODS

Non-synonymous SNPs of ADGRE2 were retrieved from the ENSEMBL, COSMIC, and gnomAD genome browsers, and the pathogenicity of deleterious variants was assessed using several established computational tools, including SIFT, CADD, REVEL, PolyPhen, and MetaLR.

RESULTS

Various in silico analyses explored the impact of damaging SNP on the function, stability, and structure of EGF-like modules containing mucin-like hormone receptor-like2 (EMR2) protein encoded by the ADGRE2 gene. Genotype analysis was performed on collected blood samples, revealing that altered genotype TT of variant rs765071211 (C/T) was associated significantly with CML patients compared to the control. Further in vitro and in vivo analyses suggest that this SNP holds potential for clinical translation.

Для цитирования: Afzal Ayesha, Jamshaid Harooma, Badshah Yasmin, Shabbir Maria, Trembley Janeen H, Zafar Sameen, Kamal Ghulam Murtaza, Afsar Tayyaba, Husain Fohad Mabood, Razak Suhail. Investigating the role of non-synonymous variant D67N of ADGRE2 in chronic myeloid leukemia.. BMC cancer. 2024. DOI: 10.1186/s12885-024-13108-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.